The Ultimate Guide to bioanalytical method validation for Drug Development and Testing

by Maria B. Medical Expert

One of the most important challenges faced by the pharmaceutical industry today is looking for innovative and integrated ways to:

· Increase their productivity

· Cut down cost

· Develop new remedies that improve human health

The employment and utilization of analytical technologies and high-output automated platforms are incorporated; to conduct more experiments in shorter time frames with increased data quality.

Purpose of Bioanalytical Method Development

The Food and Drug Administration (FDA) formulates the final guidance for industries. The latest scientific feedback is given regarding bioanalytical methods. It also provides the most advanced information needed by drug developers to make sure of the bioanalytical quality of their figures. Therefore, the purpose of FDA Bioanalytical Method development is to label the design, the limitations, and suitability of the method. It also states guidelines to manage operating conditions for its proposed purpose and to make certain that the method is optimized for validation.

Method development entails the optimization of the procedures and conditions involved with the process of extraction and detection of the analyte. Before the development and execution of any particular Bioanalytical method, the sponsor should recognize the analyte of interest.

For instance, determining the physicochemical properties of a drug product and its in-vitro and in-vivo metabolism, along with protein binding) and consider every facet of any prior analytical methods that might be applicable.

Process of Bioanalytical Method Development

The process of Bioanalysis and the production of toxicokinetic, pharmacokinetic, and metabolic data plays an elementary role in drug discovery, research, and development. Method development consists of the optimization of the following Bioanalytical parameters to ensure that the method is appropriate for validation:

· Reference standards

· Critical reagents

· Sensitivity

· Selectivity and specificity

· Calibration curve

· Accuracy

· Precision

· Quality control samples (QCs)

· Recovery

· Stability of the analyte in the matrix

The Bioanalytical method development does not require an all-embracing record-keeping process. However, the sponsor is required to record all alterations to the procedures. They are required to document all issues and the subsequent clarification or rectification, during the development process of the Bioanalytical method. The documents provide proof of an underlying principle.

Things To Consider For Bioanalytical Method Development

Bioanalytical method validation requires that the optimized method is well suited to the analysis of the study samples. The sponsor should:

• Conduct a thorough validation of the bioanalytical method that looks into the study of the new drug entity, its metabolite(s), etc.

• Conduct a thorough validation for any revisions implemented to an existing validated method.

• Record a detailed and written description for the bioanalytical method used before initiating the process of validation. The description must address the critical parameters used in the method right from the time of collection to analysis.

• Document all experiments used in the entire process for concluding the validity of the method.

• Validate the measurement of the analyte in the biological matrix.

To know more about Analytical Biolab click on link.